Senseonics Holdings Inc (NYSEAMERICAN:SENS)’s share price was down 10.4% during trading on Friday . The stock traded as low as $0.93 and last traded at $0.95, approximately 1,462,815 shares traded hands during mid-day trading. An increase of 36% from the average daily volume of 1,078,946 shares. The stock had previously closed at $1.06.
Several equities research analysts have commented on SENS shares. Stifel Nicolaus started coverage on Senseonics in a report on Tuesday, October 22nd. They issued a “buy” rating and a $2.00 target price on the stock. Craig Hallum downgraded Senseonics from a “buy” rating to a “hold” rating and set a $2.50 target price on the stock. in a report on Wednesday, November 13th. Finally, Canaccord Genuity downgraded Senseonics from a “buy” rating to a “hold” rating and dropped their target price for the stock from $2.00 to $1.00 in a report on Wednesday, November 13th. One analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $1.90.
The firm’s fifty day simple moving average is $1.07.
Senseonics (NYSEAMERICAN:SENS) last announced its quarterly earnings results on Tuesday, November 12th. The company reported ($0.16) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.16). The business had revenue of $4.32 million for the quarter, compared to the consensus estimate of $6.18 million.
Large investors have recently made changes to their positions in the company. Marshall Wace LLP purchased a new stake in Senseonics during the first quarter valued at $272,000. Bank of Montreal Can increased its position in Senseonics by 236.4% during the second quarter. Bank of Montreal Can now owns 14,513 shares of the company’s stock valued at $29,000 after acquiring an additional 10,199 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in Senseonics by 3.9% during the second quarter. Charles Schwab Investment Management Inc. now owns 515,464 shares of the company’s stock valued at $1,052,000 after acquiring an additional 19,330 shares during the last quarter. Bank of New York Mellon Corp increased its position in Senseonics by 5.6% in the second quarter. Bank of New York Mellon Corp now owns 388,449 shares of the company’s stock worth $792,000 after buying an additional 20,755 shares in the last quarter. Finally, Northern Trust Corp increased its position in Senseonics by 2.7% in the second quarter. Northern Trust Corp now owns 1,023,395 shares of the company’s stock worth $2,088,000 after buying an additional 26,906 shares in the last quarter. 30.66% of the stock is currently owned by hedge funds and other institutional investors.
Senseonics Company Profile (NYSEAMERICAN:SENS)
Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.
See Also: Support Level
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.